eventsblanner
   
   
Next Steps and New Models: Innovative Finance for Global Health R&D
October 11, 2012
London

Financing research and development into diseases that affect primarily the globe's poorest people is a significant challenge. It was the topic of a successful Financial Innovations Lab in June 2012 - and a discussion we continued in October 2012 at a follow-up Lab in London.

"Next Steps and New Models: Innovative Finance for Global Health R&D" builds on the results of the first discussion. With a goal of promoting wider implementation among industry stakeholders, participants analyzed the models outlined in the Institute's report from the June Lab, from a new advance market commitment and international finance facility to new equity funds and debt products.

They also reviewed the current financial mechanisms to make aid more efficient and effective, as well as addressed new models to engage the capital markets through various impact investing platforms. The Lab, held with support from the Bill & Melinda Gates Foundation, provided an opportunity to map out next steps toward increased adoption of the relevant models.

Results from the Lab, including recommended next steps for implementation, can be found here. For more information, contact Caitlin MacLean, senior manager of Financial Innovations Labs, at cmaclean@milkeninstitute.org